Terms: = Prostate cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Treatment
223 results:
1. Patterns of B-cell lymphocyte expression changes in pre- and post-malignant prostate tissue are associated with prostate cancer progression.
Sadasivan SM; Loveless IM; Chen Y; Gupta NS; Sanii R; Bobbitt KR; Chitale DA; Williamson SR; Rundle AG; Rybicki BA
Cancer Med; 2024 Mar; 13(6):e7118. PubMed ID: 38523528
[TBL] [Abstract] [Full Text] [Related]
2. Aloe-Emodin Isolated from
He MT; Nguyen QN; Cho EJ; Kim SH; Park S; Park JY; Lee S; Kang KS
J Diet Suppl; 2024; 21(3):389-407. PubMed ID: 38062982
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
4. SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer.
Zielske SP; Chen W; Ibrahim KG; Cackowski FC
BMC Cancer; 2023 Jul; 23(1):672. PubMed ID: 37464317
[TBL] [Abstract] [Full Text] [Related]
5. Dependency of Tamoxifen Sensitive and Resistant ER
Bhasin S; Dusek C; Peacock JW; Cherkasov A; Wang Y; Gleave M; Ong CJ
Cells; 2023 Jun; 12(13):. PubMed ID: 37443749
[TBL] [Abstract] [Full Text] [Related]
6. CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m
Qi F; Shen W; Wei X; Cheng Y; Xu F; Zheng Y; Li L; Qin C; Li X
Cell Mol Life Sci; 2023 May; 80(6):156. PubMed ID: 37208565
[TBL] [Abstract] [Full Text] [Related]
7. Infiltrating immune cells in prostate cancer tissue after androgen deprivation and radiotherapy.
Erlandsson A; Lundholm M; Watz J; Bergh A; Petrova E; Alamdari F; Helleday T; Davidsson S; Andren O; Tarish F
Int J Immunopathol Pharmacol; 2023; 37():3946320231158025. PubMed ID: 36880147
[TBL] [Abstract] [Full Text] [Related]
8. NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation.
Zhang P; Chen L; Zhou F; He Z; Wang G; Luo Y
Cell Death Dis; 2023 Feb; 14(2):159. PubMed ID: 36841806
[TBL] [Abstract] [Full Text] [Related]
9. LQB-118 Suppresses Migration and Invasion of prostate cancer Cells by Modulating the Akt/GSK3β Pathway and MMP-9/Reck Gene Expression.
Martino T; DE Bem GF; Santos SVM; Coelho MGP; Resende AC; Netto C; Costa PRR; Justo G; Sabino KCC
Anticancer Res; 2023 Jan; 43(1):359-367. PubMed ID: 36585169
[TBL] [Abstract] [Full Text] [Related]
10. The Role of Radiolabeled Monoclonal Antibodies in cancer Imaging and ADC treatment.
Martiniova L; Zielinski RJ; Lin M; DePalatis L; Ravizzini GC
Cancer J; 2022 Nov-Dec 01; 28(6):446-453. PubMed ID: 36383907
[TBL] [Abstract] [Full Text] [Related]
11. HMGB1 promotes the development of castration‑resistant prostate cancer by regulating androgen receptor activation.
Chen J; Xu D; Wang T; Yang Z; Yang Y; He K; Zhao L
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36129149
[TBL] [Abstract] [Full Text] [Related]
12. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
[TBL] [Abstract] [Full Text] [Related]
13. Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of prostate cancer through PI3K/AKT/NF-
Lei Y; Chan M; Liu H; Lyu W; Chen L; Zhong Y; Gan H; Wang M; Qi M; Guo Y; Liu J; Zhang E
Dis Markers; 2022; 2022():4399334. PubMed ID: 35899176
[TBL] [Abstract] [Full Text] [Related]
14. Development of cancer Immunotherapies.
DeLucia DC; Lee JK
Cancer Treat Res; 2022; 183():1-48. PubMed ID: 35551655
[TBL] [Abstract] [Full Text] [Related]
15. Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma.
Armstrong AJ; Nixon AB; Carmack A; Yang Q; Eisen T; Stadler WM; Jones RJ; Garcia JA; Vaishampayan UN; Picus J; Hawkins RE; Hainsworth JD; Kollmannsberger CK; Logan TF; Puzanov I; Pickering LM; Ryan CW; Protheroe A; George DJ; Halabi S
Clin Cancer Res; 2021 Jun; 27(12):3317-3328. PubMed ID: 33593885
[TBL] [Abstract] [Full Text] [Related]
16. [A Case of Synchronous Triple cancer of the Stomach, Intrahepatic Bile Duct, and prostate].
Tanaka S; Okazaki T; Owada Y; Iwabuchi S; Hosono M; Kawasaki K
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2346-2348. PubMed ID: 33468956
[TBL] [Abstract] [Full Text] [Related]
17. Androgen receptor splicing variant 7 (ARV7) inhibits docetaxel sensitivity by inactivating the spindle assembly checkpoint.
Yu B; Liu Y; Luo H; Fu J; Li Y; Shao C
J Biol Chem; 2021; 296():100276. PubMed ID: 33428943
[TBL] [Abstract] [Full Text] [Related]
18. Quantitative MRI: Defining repeatability, reproducibility and accuracy for prostate cancer imaging biomarker development.
Wang Y; Tadimalla S; Rai R; Goodwin J; Foster S; Liney G; Holloway L; Haworth A
Magn Reson Imaging; 2021 Apr; 77():169-179. PubMed ID: 33388362
[TBL] [Abstract] [Full Text] [Related]
19. TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the treatment of Solid Tumors.
Austin RJ; Lemon BD; Aaron WH; Barath M; Culp PA; DuBridge RB; Evnin LB; Jones A; Panchal A; Patnaik P; Ramakrishnan V; Rocha SS; Seto P; Sexton K; Strobel KL; Wall R; Yu S; Yu TZ; Law CL; Baeuerle PA; Wesche H
Mol Cancer Ther; 2021 Jan; 20(1):109-120. PubMed ID: 33203731
[TBL] [Abstract] [Full Text] [Related]
20. Current Status and Application of Metformin for prostate cancer: A Comprehensive Review.
Ahn HK; Lee YH; Koo KC
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198356
[TBL] [Abstract] [Full Text] [Related]
[Next]
